Mechanisms of retinal angiogenesis
Mechanisms of retinal angiogenesis
批准号:
9910397
负责人:
GADIPARTHI N RAO
金额:
$34.2万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2022-03-31
关键词:
AbbreviationsAddressAge related macular degenerationBlindnessBlood VesselsCDC6 geneCREB1 geneCRISPR/Cas technologyCell Culture TechniquesCell CycleChromosomesDNADNA biosynthesisDevelopmentDiseaseDominant-Negative MutationDown-RegulationEndothelial CellsEventFundingGene SilencingHemorrhageHumanHypoxiaIn VitroIsoenzymesKnockout MiceLeadMCM2 geneMaintenanceMediatingModelingMolecularNOTCH1 genePathologicPericytesPharmacologyPhospholipase CPlayPre-Replication ComplexProtein KinaseProteinsRNA InterferenceReportingRetinaRetinal DiseasesRetinal NeovascularizationRoleSignal TransductionSmall Interfering RNATestingTime StudyTubeVEGFA geneVEGFC geneVascular Endothelial Growth Factor Receptor-1Vascular Permeabilitiesbaseblood vessel developmentchromatin immunoprecipitationcofilincombinatorialexperimental studyin vivomigrationmouse modelneovascularizationneutralizing antibodynovelnovel therapeuticsnuclear factors of activated T-cellsprotein kinase C gammaresponseretinal angiogenesissmall hairpin RNAtherapeutic development
中文摘要
以前我们已经证明Src-PLD 1-PKCγ-cPLA 2信号通路参与视网膜神经元的调节,
新生血管形成我们的研究还表明,Pak 1-cofilin信号轴的激活是
视网膜新生血管形成所必需的。此外,我们已经表明,除了VEGFA,VEGFC通过CREB-
DLL 4-NOTCH 1信号通路介导的激活在HRMVEC的增强中起重要作用
在体外细胞培养模型和视网膜中的迁移、增殖、发芽和管形成
OIR模型中的体内新血管形成。在这些研究过程中,我们发现VEGFA和
低氧刺激PKCθ非常强烈,其水平的耗尽完全阻断了迁移和发芽
HRMVEC响应VEGFA的能力。我们还观察到VEGFA和缺氧都诱导了
Flt 4的表达非常强烈,这种反应需要PKCθ介导的JunB诱导。此外,双方
VEGFA和缺氧触发了CDC 6表达的诱导,CDC 6是复制前的调节成分。
复合物(前RC)并参与将迷你染色体维持蛋白(MCM 2 -7)加载到
DNA,它在复制中起着限速作用。此外,下调CDC 6水平完全
消除VEGF诱导的DNA合成。基于这些新发现,我们提出PKCθ通过
增强EC迁移和出芽以及CDC 6通过增强EC增殖在
调节视网膜新生血管。为了验证这一核心假设,我们将讨论以下四个具体问题。
目标。目标1。探讨PKCθ介导缺氧诱导的视网膜新生血管形成。目标二。到
检验JunB介导缺氧诱导的视网膜新生血管形成的假设。目标3。测试
假设PKCθ-JunB信号轴靶向Flt 4诱导介导视网膜新生血管形成。目标4。
为了验证CDC 6在视网膜新生血管形成中起重要作用的假设。的结果
提出的实验可能提供新的信息方面的分子机制,
病理性视网膜新生血管形成,这可能导致新的治疗化合物的开发
对抗这种眼病
英文摘要
Previously we have demonstrated that Src-PLD1-PKCγ-cPLA2 signaling is involved in the modulation of retinal
neovascularization. Our studies have also demonstrated that activation of Pak1-cofilin signaling axis is
required for retinal neovascularization. Furthermore, we have shown that besides VEGFA, VEGFC via CREB-
mediated activation of DLL4-NOTCH1 signaling plays an important role in the enhancement of HRMVEC
migration, proliferation, sprouting and tube formation in vitro in a cell culture model and retinal
neovascularization in vivo in an OIR model. During the course of these studies, we found that both VEGFA and
hypoxia stimulate PKCθ very robustly and depletion of its levels completely blocks the migrating and sprouting
capacity of HRMVECs in response to VEGFA. We have also observed that both VEGFA and hypoxia induce
Flt4 expression profoundly and this response requires PKCθ-mediated JunB induction. Furthermore, both
VEGFA and hypoxia triggered the induction of expression of CDC6, a regulatory component of pre-replication
complex (pre-RC) and involved in loading the mini chromosome maintenance proteins (MCM2-7) onto the
DNA, which plays a rate-limiting step in replication. In addition, down regulation of CDC6 levels completely
abolished VEGFA-induced DNA synthesis. Based on these novel discoveries, we propose that PKCθ via
enhancing EC migration and sprouting and CDC6 via enhancing EC proliferation play an integral role in the
modulation retinal neovascularization. To test this central hypothesis, we will address the following four specific
aims. Aim 1. To test the hypothesis that PKCθ mediates hypoxia-induced retinal neovascularization. Aim 2. To
test the hypothesis that JunB mediates hypoxia-induced retinal neovascularization. Aim 3. To test the
hypothesis that PKCθ-JunB signaling axis targets Flt4 induction in mediating retinal neovascularization. Aim 4.
To test the hypothesis that CDC6 plays an essential role in retinal neovascularization. The results of the
proposed experiments may provide novel information in regard to the molecular mechanisms underling
pathological retinal neovascularization, which could lead to the development of new therapeutic compounds
against this ocular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GRP78 signaling and retinal angiogenesis
-
批准号:10728654
-
项目类别:
-
资助金额:$51.11万
-
财政年份:2023
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling & Vascular Wall Remodeling
-
批准号:8444697
-
项目类别:
-
资助金额:$44.1万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling & Vascular Wall Remodeling
-
批准号:8644301
-
项目类别:
-
资助金额:$45.39万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling & Vascular Wall Remodeling
-
批准号:8092058
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling and Vascular Wall Remodeling
-
批准号:9312305
-
项目类别:
-
资助金额:$47.59万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling & Vascular Wall Remodeling
-
批准号:8817309
-
项目类别:
-
资助金额:$45.62万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling & Vascular Wall Remodeling
-
批准号:8249048
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
GPCR Signaling and Vascular Wall Remodeling
-
批准号:9193490
-
项目类别:
-
资助金额:$45.19万
-
财政年份:2011
-
负责人:GADIPARTHI N RAO
-
依托单位:
Mechanisms of retinal angiogenesis
-
批准号:8774905
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Mechanisms of retinal angiogenesis
-
批准号:8979691
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Mechanisms of retinal angiogenesis
-
批准号:8453956
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Phospholipases and retinal angiogenesis
-
批准号:7894617
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Mechanisms of retinal angiogenesis
-
批准号:8586313
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Phospholipases and retinal angiogenesis
-
批准号:8117500
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
EICOSANOIDS, ANGIOGENESIS, AND RETINOPATHY
-
批准号:7433842
-
项目类别:
-
资助金额:$34.73万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Phospholipases and retinal angiogenesis
-
批准号:7714791
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
EICOSANOIDS, ANGIOGENESIS, AND RETINOPATHY
-
批准号:7029150
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
EICOSANOIDS, ANGIOGENESIS, AND RETINOPATHY
-
批准号:7238555
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2006
-
负责人:GADIPARTHI N RAO
-
依托单位:
Non-COX Arachidonic Acid Metabolites and Angiogenesis
-
批准号:7025691
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2004
-
负责人:GADIPARTHI N RAO
-
依托单位:
Eicosanoids and Endothelial Cell Dysfunction
-
批准号:8451471
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2004
-
负责人:GADIPARTHI N RAO
-
依托单位:
海外基金